Conservest Capital Advisors’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $325K | Buy |
1,280
+95
| +8% | +$22.1K | 0.03% | 115 |
|
|
2026
Q1 | $290K | Buy |
1,185
+42
| +4% | +$9.78K | 0.03% | 106 |
|
|
2025
Q4 | $236K | Buy |
1,143
+3
| +0.3% | +$593 | 0.02% | 119 |
|
|
2025
Q3 | $211K | Buy |
+1,140
| New | +$195K | 0.02% | 123 |
|
|
2024
Q4 | – | Sell |
-1,676
| Closed | -$265K | – | 114 |
|
|
2024
Q3 | $265K | Hold |
1,676
| – | – | 0.03% | 91 |
|
|
2024
Q2 | $265K | Hold |
1,676
| – | – | 0.03% | 90 |
|
|
2024
Q1 | $265K | Sell |
1,676
-94
| -5% | -$15K | 0.03% | 91 |
|
|
2023
Q4 | $278K | Buy |
1,770
+171
| +11% | +$26.2K | 0.03% | 89 |
|
|
2023
Q3 | $249K | Buy |
1,599
+5
| +0.3% | +$825 | 0.03% | 84 |
|
|
2023
Q2 | $264K | Sell |
1,594
-313
| -16% | -$50.5K | 0.03% | 85 |
|
|
2023
Q1 | $296K | Buy |
1,907
+17
| +0.9% | +$2.75K | 0.04% | 79 |
|
|
2022
Q4 | $334K | Buy |
+1,890
| New | +$326K | 0.04% | 68 |
|
|
2022
Q3 | – | Sell |
-1,980
| Closed | -$335K | – | 65 |
|
|
2022
Q2 | $351K | Buy |
1,980
+534
| +37% | +$95.1K | 0.04% | 66 |
|
|
2022
Q1 | $256K | Sell |
1,446
-48
| -3% | -$8.17K | 0.03% | 75 |
|
|
2021
Q4 | $256K | Buy |
1,494
+57
| +4% | +$9.33K | 0.03% | 80 |
|
|
2021
Q3 | $232K | Buy |
1,437
+4
| +0.3% | +$682 | 0.03% | 74 |
|
|
2021
Q2 | $236K | Buy |
1,433
+4
| +0.3% | +$662 | 0.03% | 75 |
|
|
2021
Q1 | $235K | Buy |
1,429
+98
| +7% | +$15.9K | 0.03% | 72 |
|
|
2020
Q4 | $209K | Buy |
+1,331
| New | +$196K | 0.03% | 76 |
|
|
2020
Q2 | – | Sell |
-1,627
| Closed | -$213K | – | 72 |
|
|
2020
Q1 | $213K | Sell |
1,627
-31
| -2% | -$4.4K | 0.04% | 65 |
|
|
2019
Q4 | $242K | Sell |
1,658
-96
| -5% | -$13K | 0.03% | 73 |
|
|
2019
Q3 | $227K | Sell |
1,754
-288
| -14% | -$37.9K | 0.03% | 75 |
|
|
2019
Q2 | $284K | Buy |
2,042
+2
| +0.1% | +$277 | 0.04% | 70 |
|
|
2019
Q1 | $285K | Buy |
2,040
+2
| +0.1% | +$268 | 0.04% | 69 |
|
|
2018
Q4 | $263K | Sell |
2,038
-5,950
| -74% | -$830K | 0.04% | 68 |
|
|
2018
Q3 | $1.1M | Sell |
7,988
-104
| -1% | -$13.8K | 0.16% | 42 |
|
|
2018
Q2 | $982K | Sell |
8,092
-7,260
| -47% | -$906K | 0.15% | 45 |
|
|
2018
Q1 | $1.97M | Sell |
15,352
-2,075
| -12% | -$280K | 0.43% | 30 |
|
|
2017
Q4 | $2.44M | Buy |
17,427
+149
| +0.9% | +$20.8K | 0.48% | 32 |
|
|
2017
Q3 | $2.25M | Buy |
17,278
+280
| +2% | +$37.1K | 0.36% | 40 |
|
|
2017
Q2 | $2.25M | Buy |
16,998
+2
| +0% | +$255 | 0.48% | 28 |
|
|
2017
Q1 | $2.12M | Buy |
+16,996
| New | +$2.03M | 0.45% | 30 |
|
Other funds holding JNJ
AACR
Conservest Capital Advisors's JNJ Position: Q2 2026 in Review
Conservest Capital Advisors increased its Johnson & Johnson (JNJ) stake by 8% in Q2 2026, buying an estimated $22.1K and bringing the position to 1,280 shares worth $325K. The position accounts for 0.03% of the portfolio, ranked #115.
Conservest Capital Advisors first reported a position in JNJ in Q1 2017 and has held it in 32 quarters since. The position peaked at $2.44M in Q4 2017. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Conservest Capital Advisors held 1,280 shares of Johnson & Johnson worth $325K as of Q2 2026.
- Conservest Capital Advisors bought 95 Johnson & Johnson shares in Q2 2026, an estimated $22.1K.
- Johnson & Johnson made up 0.03% of Conservest Capital Advisors's portfolio in Q2 2026, its #115 holding.
- Conservest Capital Advisors first reported a position in Johnson & Johnson in Q1 2017 and has held it in 32 quarters since.
- Conservest Capital Advisors's Johnson & Johnson position peaked at $2.44M in Q4 2017.
- 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Conservest Capital Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.